The Computer-Aided Drug Discovery market was valued at USD 6.5 billion in 2024 and is anticipated to reach USD 13.44 billion by 2033, growing at a robust CAGR of 8.4% from 2025 to 2033. The Computer-Aided Drug Discovery (CADD) market is steadily gaining traction as pharmaceutical and biotech firms increasingly leverage computational tools—such as molecular modeling, artificial intelligence, and big-data analytics—to streamline and accelerate drug discovery. These technologies reduce time and cost while improving the identification and optimization of drug candidates. Growth is driven by the rising demand for faster, more cost-effective, and precise drug development in response to pressing healthcare needs. Among key trends are the integration of AI/ML into discovery pipelines, cloud-based platforms, and personalized medicine initiatives. Leading players in this space include Dassault Systèmes, PerkinElmer, Schrödinger, Certara, Exscientia, Insilico Medicine, and OpenEye, among others, all pushing the boundaries of computational drug design. The report further explores the key business players along with their in-depth profiling, including Dassault Systèmes, PerkinElmer Inc., Schrödinger Inc., Certara Inc., Charles River Laboratories International Inc., Evotec SE, OpenEye Scientific Software Inc., Chemical Computing Group ULC, Simulation Plus Inc., and Selvita S.A. The market is segmented by drug type (small molecules, biologics), technology (structure-based drug design, ligand-based drug design, sequence-based approaches, AI & machine learning integrated methods, others), therapeutic area (oncology, neurological disorders, cardiovascular diseases, infectious diseases, others), and end user (pharmaceutical & biotechnology companies, contract research organizations (CROs), academic & research institutes). The report discusses factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. It also highlights emerging trends, challenges, limitations, and growth opportunities. A competitive landscape analysis examines major and emerging market players in terms of market share, gross margin, product portfolio, production, revenue, sales growth, and other significant factors. The regional outlook covers North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC), South America (Brazil, Argentina, Rest of SA), and the Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA), with detailed revenue and sales data. Key benefits for stakeholders include a quantitative analysis of market trends, Porter's five forces study, in-depth market segmentation, and analysis of market opportunities. The report answers key questions such as the market development pace, key drivers, key manufacturers, market openings and threats, sales and revenue analysis of top manufacturers, distribution networks, market opportunities and threats, and deals by type and application. The study provides a forward-looking perspective on factors expected to boost market growth and offers insights into business strategies of major market players.

Computer Aided Drug Discovery Market Size Analysis

The Computer-Aided Drug Discovery (CADD) market was valued at USD 6.5 billion in 2024 and is projected to reach USD 13.44 billion by 2033, growing at a CAGR of 8.4% from 2025 to 2033. Pharmaceutical and biotech firms are increasingly adopting computational tools such as molecular modeling, artificial intelligence, and big-data analytics to accelerate drug discovery, reduce costs, and improve candidate identification. Key trends include AI/ML integration, cloud-based platforms, and personalized medicine. Major players include Dassault Systèmes, PerkinElmer, Schrödinger, Certara, Exscientia, Insilico Medicine, and OpenEye. The market is segmented by drug type, technology, therapeutic area, and end user. A competitive landscape analysis covers market share, revenue, product portfolio, and growth factors, with regional outlooks across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.